Novo Nordisk is doubling down on its collaboration ... gave Novo three cardiovascular assets and set the stage for work on up to 11 programs overall. Novo was primarily focused on cardiovascular ...

Collaboration aims to identify and validate novel targets with strong genetic evidence and clear therapeutic hypotheses The partnership between Novo Nordisk ... VB-Inference maps the molecular ...

The “magnificent seven” tech stocks have helped drive the U.S. stock market to record highs. Their soaring valuations imply ...

"Trump might forget about Greenland. But also, he might not. Nobody knows. He operates on whims," @anneapplebaum writes.

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

We can thank Jens and Lars Rasmussen for Google Maps. It was a Danish mycologist ... from the big pharmaceutical company Novo Nordisk. Wait a second. This doesn’t make any sense.

These diabetes and weight loss drugs work by slowing digestion and curbing ... In a statement sent to USA TODAY, a spokesperson for drug maker Novo Nordisk said the company welcomes any ...

Robert F. Kennedy Jr., President Trump’s nominee for health secretary, repeatedly confused Medicare and Medicaid. He also ...

The highly anticipated Best Places to Work World Rankings for 2024 have ... fostering a forward-thinking and inclusive workplace. Novo Nordisk –A global healthcare company with over 95 ...

and to work with like-minded suppliers. One way to ensure that Novo Nordisk’s approach to sustainability is carried through all parts of the business has been the way it has approached educating ...